Schedule 13G ownership disclosure

Zomedica Pharmaceuticals Corp.

Security class unavailable · CUSIP: 98979F107

Event date: 2020-02-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,333,334
Percent of class
6.4700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-20-000072
Form type
SC 13G
Filer
SABBY MANAGEMENT, LLC
CIK
CIK 1535610
Filed
Feb 12, 2020
Reporting period
Feb 12, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub